# Preclinical Therapeutics Shared Resource

> **NIH NIH P30** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2022 · $443,109

## Abstract

Preclinical Therapeutics Shared Resource: Summary/Abstract 
The goal of the Preclinical Therapeutics Shared Resource (PCT) is to provide streamlined in vivo preclinical 
therapeutic services and training to HDFCCC members. The PCT uses state-of-the-art rodent cancer models, 
therapeutic delivery modalities, and live imaging technologies to facilitate generation of high-quality data that 
may be translated into clinical oncology research. The PCT facilitates translational research by providing a full 
suite of in vivo rodent services to HDFCCC investigators. The PCT ensures a stable infrastructure for small 
rodent cancer studies within a specific pathogen-free (SPF) barrier, facilitating rigor and reproducibility, cost- 
effectiveness, and quality control.

## Key facts

- **NIH application ID:** 10406943
- **Project number:** 5P30CA082103-23
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** ROSEMARY J AKHURST
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $443,109
- **Award type:** 5
- **Project period:** 1999-08-05 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10406943

## Citation

> US National Institutes of Health, RePORTER application 10406943, Preclinical Therapeutics Shared Resource (5P30CA082103-23). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10406943. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*